Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome

Nucleic Acids Research(2023)10.1093/nar/gkac1238Source: DataRank Database

Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome is a research paper published in Nucleic Acids Research (2023). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

bioproject gisaid pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 10.89)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hirotaka Ode ORCID,Mai Kubota,Takaaki Kasahara,Kazuhiro Matsuoka ORCID,Atsuko Sugimoto

Live enrichment

PubMed:36610792 PMC:PMC9881129 OpenAlex:https://openalex.org/W4313705748

Japan Society for the Promotion of Science

Grant: KAKENHI

Japan Society for the Promotion of Science

Grant: 19H03482

Japan Agency for Medical Research and Development

Grant: 20fk0108293h0001

Japan Agency for Medical Research and Development

Grant: 20fk0108536s0301

Japan Science and Technology Agency

Grant: JST SPRING

Japan Science and Technology Agency

Grant: JPMJSP2125

FWCI

10.89

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://academic.oup.com/nar/article-pdf/51/2/783/48929191/gkac1238.pdf

publisherhttps://academic.oup.com/nar/article-pdf/51/2/783/48929191/gkac1238.pdf

journalhttps://doi.org/10.1093/nar/gkac1238

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36610792

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9881129

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks Researchinterferon and immune responsesHumansCOVID-19Cytidine DeaminaseGenome, ViralMutationRNA, ViralSARS-CoV-2Tumor Necrosis Factor-alphaProteins

MeSH Terms

COVID-19SARS-CoV-2Cytidine DeaminaseHumansMutationProteinsRNA, ViralTumor Necrosis Factor-alphaGenome, Viral

Keywords

BiologyCytidine deaminaseGeneticsVirologyGenomeMutationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Gene

Sustainable Development Goals

SDG 0: Good health and well-being

Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome

FAIR Checklist

Authors (9)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)